login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Endovascular treatment for diabetic foot syndrome shows nearly 83% freedom from amputation


Thursday, 20 Oct 2011 13:51

A study first published online on 12 September in the Journal of Interventional Cardiology suggests that endovascular treatment of diabetic foot syndrome using mixed coronary and peripheral materials and techniques leads to high immediate success and limb salvage rates compared to historical series.


Authors of the study, Paolo Cardaioli, department of Interventional Cardiology, University of Padova Medical School, Padova, Italy et al set out to assess the long-term results of interventional treatment of diabetic foot using mixed coronary and peripheral equipments and techniques.


A diabetic foot exhibits any pathology that results directly from diabetes mellitus or any chronic complication of diabetes mellitus. Presence of several characteristic diabetic foot pathologies is called diabetic foot syndrome. Interventional treatment for the diabetic foot is rapidly becoming the therapy of choice for patients, but proper materials and techniques are still debated, wrote the authors.


The investigators prospectively enrolled 220 diabetic patients (78.5±15.8 years, 107 female, all with Fontaine III or IV class) from January 2006 to December 2010 who were referred to our center for diabetic foot syndrome and severe limb ischaemia. They used techniques using both coronary and peripheral guidewires and balloons. Doppler ultrasonography and foot transcutaneous oxygen pressure (TcPO2) before and after the procedure were calculated as well as the amputation rate.


Cardaioli et al point out that the preferred approach was ipsilateral femoral antegrade in 170/220 patients (77.7%), contralateral cross-over in 40/220 patients (18.8%), and popliteal retrograde plus femoral antegrade in 10/220 patients (4.5%).


They explain that the techniques included combined use of coronary and dedicated peripheral guidewires and coronary and peripheral dedicated balloons. “Percutaneous balloon angioplasty was performed in 252 legs, and contributing to these were 32 patients with bilateral disease. The procedure was successful in 239/252 legs with an immediate success rate of 94.8% and a significant improvement in TcPO2 and ankle-brachial index with ulcer healing in 233/252 legs (92.4%).” Authors wrote that the freedom from major amputation was 82.8% at a mean follow-up of 3.1±1.8 years (range one to five years).




Add New Comment

Related Items


Most popular


Cyanoacrylate embolisation agent non-inferior to radiofrequency ablation for incompetent great saphenous veins treatment
Friday, 03 Jul 2015
Twelve-month results from the VeClose trial have demonstrated cyanoacrylate adhesive (CAE) is non-inferior to radiofrequency ablation (RFA) for the treatment of incompetent great saphenous veins. Cyanoacrylate embolisation agent non-inferior to radiofrequency ablation for incompetent great saphenous veins treatment

Biolas introduces VariClose in Europe
Thursday, 16 Jul 2015
After the European launch in April 2015, Biolas has introduced the VariClose Vein Sealing Systems in the European market for the treatment of varicose veins. Biolas introduces VariClose in Europe

Lombard Medical acquires EVAR stent graft developer Altura Medical
Friday, 31 Jul 2015
Altura Medical has developed an ultra-low profile endovascular stent graft technology that, according to Lombard, offers a simple and predictable solution for the treatment of standard abdominal ... Lombard Medical acquires EVAR stent graft developer Altura Medical

Features


Patient selection is key for SIRT with first-line chemotherapy
Tuesday, 18 Aug 2015
Ricky Sharma, professor and honorary consultant of Clinical Oncology at the University of Oxford and Oxford University Hospitals Trust tells Interventional News: “We need to know more about patient ... Patient selection is key for SIRT with first-line chemotherapy

Choosing horses for courses: Using liquid agents to embolize endoleaks
Monday, 27 Jul 2015
Robert Morgan, vascular interventional radiologist, St Georges Hospital, London, UK, tells Interventional News why he uses liquid embolic agents, such as ethylene vinyl oxide copolymer (EVOH-based) ... Choosing horses for courses: Using liquid agents to embolize endoleaks

Profiles


Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions